166977-43-1

166977-43-1 structure

Name: BMS 453
Chemical Name: 4-[(E)-2-(5,5-Dimethyl-8-phenyl-5,6-dihydro-2-naphthalenyl)vinyl] benzoic acid
CAS Number: 166977-43-1
Molecular Formula: C₂₇H₂₄O₂
Molecular Weight: 380.47800
Catalog: Signaling Pathways Metabolic Enzyme/Protease RAR/RXR
Create Date: 2016-12-28 17:32:02
Modify Date: 2024-01-09 15:07:19
BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[1][2].

Name	4-[(E)-2-(5,5-Dimethyl-8-phenyl-5,6-dihydro-2-naphthalenyl)vinyl] benzoic acid
Synonyms	BMS-189453

Description	BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR
In Vitro	BMS453 (1 μM; 11 hours; 184 and HMEC cells) treatment inhibits the proliferation of normal breast cell growth without significantly inducing apoptosis[2]. BMS453 (1 μM; 5 days; 184 and HMEC cells) treatment inhibits normal breast cell proliferation by causing G1 arrest[2]. BMS453 (1 μM; 24-72 hours; 184 cells) treatment induces Rb hypophosphorylation and decrease CDK2 kinase activity. BMS453 increases total p21 protein levels and CDK2-bound p21 protein, but does not change CDK4-bound p21[2]. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ[2]. Cell Proliferation Assay[2] Cell Line: Normal human mammary epithelial cells (184 and HMEC) Concentration: 1 μM Incubation Time: 11 hours Result: Inhibited 3H-thymidine uptake in normal breast cells (184 and HMEC) by 40 %. Cell Cycle Analysis[2] Cell Line: Normal human mammary epithelial cells (184 and HMEC) Concentration: 1 μM Incubation Time: 5 days Result: Increased the proportion of cells in G0/G1 phase and decreased the proportion of cells in S phase. Western Blot Analysis[2] Cell Line: 184 cells Concentration: 1 μM Incubation Time: 24 hours, 48 hours, 72 hours Result: Induced Rb hypophosphorylation and decrease CDK2 kinase activity.
References	[1]. J Y Chen, et al. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 1995 Mar 15;14(6):1187-97. [2]. L Yang, et al. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest. Oncogene. 2001 Nov 29;20(55):8025-35.

Molecular Formula	C₂₇H₂₄O₂
Molecular Weight	380.47800
Exact Mass	380.17800
PSA	37.30000
LogP	6.66820

RIDADR	NONH for all modes of transport

166977-43-1	1549811-36-0
1675201-90-7	543730-41-2
1781932-33-9	1174046-72-0
918348-67-1	253174-92-4
1319719-58-8	1059734-66-5
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	2228923-98-4
1375289-11-4	849349-65-1